Email
Password
 

 
25/6/2010
Allergan launches new glaucoma drop!
 
 

Alert

Allergan launches new glaucoma drop!

25/6/2010 

   

 

Allergan Pharmaceuticals through their distributors Genop Healthcare recently launched GANFORT Eye Drops. GANFORT Eye Drops contain bimatoprost 0.3 mg/ml and timolol maleate equivalent to 5 mg/ml timolol and is indicated for reduction of intra-ocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to a topical beta-blocker or prostaglandin analogues given alone.

The two active substances rapidly decrease elevated intra-ocular pressure (IOP) through complementary mechanisms of action.  The combined effect results in additional IOP reduction compared to either compound administered alone.

Available on doctors prescription only!

[S4] GANFORT Eye Drops. Contains: Bimatoprost 0,3 mg/ml and Timolol maleate equivalent to 5 mg/ml timolol. Registration number:  42/15.4/0127.  Pharmacological classification: A.15.4 Ophthalmic preparations. Other. For full prescribing information refer to the package insert approved by the regulatory authority. Applicant: Allergan Pharmaceuticals (Pty) Ltd, South Africa.  Distributor:  Genop Healthcare (Pty) Ltd, P O Box 3911, Halfway House, 1685, South Africa (Co. Reg. no.  1984/011575/07) Telephone:  + 27 (011) 545 6600,    Facsimile:  + 27 (011) 315 6008, www.genophealthcare.co.za

 

Package insert for GANFORT

back to top

 

   

  Genop Healthcare 2009
  Terms of use
HOME     I     ABOUT US     I     DISTRIBUTORS     I     ORDER A PRODUCT     I     CONTACT US